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1) Initial research/organization
à Bibliographic research through PubMed
and Google Scholar
à Information extraction from MSD manual and
the database PharmGKB
à Key words: ”precision medicine”,
“pharmacogenomics”, “(pharmacogenomics)
AND citalopram”, “(pharmacogenomics) AND
CYP2C19”, “CYP2C19”
à Schedule the seminars (at INS Leonardo Da
Vinci and COILL – Col·legi de Infermeres de
Lleida)
3) Instagram
àThree main areas: posts, instastories, IGTV
videos
àPhotographs: own elaboration, with Pixabay
License or with Creative Commons LIcence
àAvatars design to explain metabolizers types
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2) Seminars
àINS Leonardo Da Vinci
(12/03/2020)
àCOILL – Col·legi de
Infermeres de Lleida
(16/04/2020 and 17/04/2020)
àContents: genetics concepts review,
personalized medicine introduction,
differences between pharmacogenetics and
pharmacogenomics, basic information about
pharmacokinetics and pharmacodynamics,
biotransformation and drug metabolism,
pharmacogenomics in the MDD treatment
(CYP2C19 and citalopram) and conclusions
àFinal survey
The main aim is to spread the pharmacogenomics and pharmacogenetics to
contribute to its future implementation. This is divided into:
→ Explain the main characteristics of it through an Instagram profile for general
Spanish speaking population
→ Awake interests to High School students, as they are the future and could take
an important role on its implementation
→ Convey to nurses that they can have an important paper removing the trial and
error treatment strategy and providing a good pharmacogenomics education
→ Personalized medicine: diagnose, treat and prevent taking into consideration the
patients’ molecular and genetic profile
→ Moving away from ”one size fits all” approach
→ Pharmacogenomics (whole genome) and pharmacogenetics (a specific gene):
predict the response to a particular drug depending on the individual genetics à
decide which treatment and dose will be more suitable
→ Major Depressive Disorder (MDD) affects 4,4% of the worldwide population. Often,
it is treated with citalopram, which is detoxified above all through CYP2C19 (an
enzyme from the CYP450 family with 4 main variants: *1, *2, *3 and *17)
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Seminar slides 
→ Survey analysis is represented in the graphs
→ 9 out of 10 was the average interest of the topic 
→ In order to receive more information is preferable the Instagram profile used and a 
YouTube channel
→ The most interesting parts were the MDD example and metabolizers explication
→ High number of followers and positive feedback from them 
----------------------------------------------------------------------------------------------------------------
→ Better videos than publications (but considering their duration)
→ More interactive and dynamic activities through @pharmacogen
→ New IGTV videos explaining practical cases (more attractive for the public)
→ Creation of a YouTube channel where uploading the videos
→ Collaborate with other scientific profiles à DIVULGATION 
→ Carrying out with the project, trying to spread the pharmacogenomics knowledge
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